{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-virulence", "Biofilm", "CrtM", "Molecular dynamics simulations", "PCAT", "Patuletin", "Staphylococcus aureus", "Staphyloxanthin"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38293404", "DateRevised": {"Year": "2024", "Month": "02", "Day": "01"}, "Article": {"Language": ["eng"], "ELocationID": ["e24075", "10.1016/j.heliyon.2024.e24075"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "06"}], "Journal": {"ISSN": "2405-8440", "JournalIssue": {"Volume": "10", "Issue": "2", "PubDate": {"Year": "2024", "Month": "Jan", "Day": "30"}}, "Title": "Heliyon", "ISOAbbreviation": "Heliyon"}, "ArticleTitle": "Anti-virulence potential of patuletin, a natural flavone, against <i>Staphylococcus aureus: In vitro</i> and <i>In silico</i> investigations.", "Pagination": {"StartPage": "e24075", "MedlinePgn": "e24075"}, "Abstract": {"AbstractText": ["<i>Staphylococcus aureus</i> is a highly prevalent and aggressive human pathogen causing a wide range of infections. This study aimed to explore the potential of Patuletin, a rare natural flavone, as an anti-virulence agent against <i>S</i>. <i>aureus</i>. At a sub-inhibitory concentration (1/4 MIC), Patuletin notably reduced biofilm formation by 27\u00a0% and 23\u00a0%, and decreased staphyloxanthin production by 53\u00a0% and 46\u00a0% in <i>Staphylococcus aureus</i> isolate SA25923 and clinical isolate SA1, respectively. In order to gain a more comprehensive understanding of the <i>in vitro</i> findings, several <i>in silico</i> analyses were conducted. Initially, a 3D-flexible alignment study demonstrated a favorable structural similarity between Patuletin and <b>B70</b>, the co-crystallized ligand of CrtM, an enzyme that plays a pivotal role in the biosynthesis of staphyloxanthin. Molecular docking highlighted the strong binding of Patuletin to the active site of CrtM, with a high affinity of -20.95\u00a0kcal/mol. Subsequent 200 ns molecular dynamics simulations, along with MM-GBSA, ProLIF, PLIP, and PCAT analyses, affirmed the stability of the Patuletin-CrtM complex, revealing no significant changes in CrtM's structure upon binding. Key amino acids crucial for binding were also identified. Collectively, this study showcased the effective inhibition of CrtM activity by Patuletin <i>in silico</i> and its attenuation of key virulence factors <i>in vitro</i>, including biofilm formation and staphyloxanthin production. These findings hint at Patuletin's potential as a valuable therapeutic agent, especially in combination with antibiotics, to counter antibiotic-resistant <i>Staphylococcus aureus</i> infections."], "CopyrightInformation": "\u00a9 2024 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}, {"Identifier": [], "Affiliation": "Biopharmaceutical Products Research Department, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Alexandria, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology and Immunology Department, Faculty of Pharmacy, Port Said University, Port Said, Egypt."}], "LastName": "Saleh", "ForeName": "Moustafa M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh, 11671, Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Bshra A", "Initials": "BA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biophysics Department, Faculty of Science, Cairo University. Giza 12613, Egypt."}], "LastName": "Ibrahim", "ForeName": "Ibrahim M", "Initials": "IM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}], "LastName": "Abd-Elraouf", "ForeName": "Muhamad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Riyadh, 13713, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Heliyon", "NlmUniqueID": "101672560", "ISSNLinking": "2405-8440"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Howden B.P., et al. Staphylococcus aureus host interactions and adaptation. Nat. Rev. Microbiol. 2023;21(6):380\u2013395.", "ArticleIdList": ["PMC9882747", "36707725"]}, {"Citation": "Lowy F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998;339(8):520\u2013532.", "ArticleIdList": ["9709046"]}, {"Citation": "Cheung G.Y.C., et al. Bacterial virulence plays a crucial role in MRSA sepsis. PLoS Pathog. 2021;17(2)", "ArticleIdList": ["PMC7942999", "33630954"]}, {"Citation": "Cheung G.Y.C., Bae J.S., Otto M. Pathogenicity and virulence of Staphylococcus aureus. Virulence. 2021;12(1):547\u2013569.", "ArticleIdList": ["PMC7872022", "33522395"]}, {"Citation": "Xue L., et al. Staphyloxanthin: a potential target for antivirulence therapy. Infect. Drug Resist. 2019;12:2151\u20132160.", "ArticleIdList": ["PMC6647007", "31410034"]}, {"Citation": "Elmesseri R.A., et al. Staphyloxanthin as a potential novel target for deciphering promising anti-Staphylococcus aureus agents. Antibiotics (Basel) 2022;11(3)", "ArticleIdList": ["PMC8944557", "35326762"]}, {"Citation": "Lin F.Y., et al. Mechanism of action and inhibition of dehydrosqualene synthase. Proc. Natl. Acad. Sci. U. S. A. 2010;107(50):21337\u201321342.", "ArticleIdList": ["PMC3003041", "21098670"]}, {"Citation": "Pelz A., et al. Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J. Biol. Chem. 2005;280(37):32493\u201332498.", "ArticleIdList": ["16020541"]}, {"Citation": "Cueno M.E., Imai K. Network analytics approach towards identifying potential antivirulence drug targets within the Staphylococcus aureus staphyloxanthin biosynthetic network. Arch. Biochem. Biophys. 2018;645:81\u201386.", "ArticleIdList": ["29551420"]}, {"Citation": "Sun E., Cohen F.E.J.G. Computer-assisted drug discovery\u2014a review. 1993;137(1):127\u2013132.", "ArticleIdList": ["8282195"]}, {"Citation": "Sadybekov A.V., Katritch V. Computational approaches streamlining drug discovery. Nature. 2023;616(7958):673\u2013685.", "ArticleIdList": ["37100941"]}, {"Citation": "Brogi S. Computational approaches for drug discovery. Molecules. 2019;24(17)", "ArticleIdList": ["PMC6749237", "31443558"]}, {"Citation": "Metwaly A.M., et al. Traditional ancient Egyptian medicine: a review. Saudi J. Biol. Sci. 2021;28(10):5823\u20135832.", "ArticleIdList": ["PMC8459052", "34588897"]}, {"Citation": "Metwaly A.M., et al. Black ginseng and its saponins: preparation, phytochemistry and pharmacological effects. Molecules. 2019;24(10):1856.", "ArticleIdList": ["PMC6572638", "31091790"]}, {"Citation": "Newman D.J., Cragg G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016;79(3):629\u2013661.", "ArticleIdList": ["26852623"]}, {"Citation": "Silva L.N., et al. Myricetin protects Galleria mellonella against Staphylococcus aureus infection and inhibits multiple virulence factors. Sci. Rep. 2017;7(1):2823.", "ArticleIdList": ["PMC5460262", "28588273"]}, {"Citation": "Vijayakumar K., Muhilvannan S., Arun Vignesh M. Hesperidin inhibits biofilm formation, virulence and staphyloxanthin synthesis in methicillin resistant Staphylococcus aureus by targeting SarA and CrtM: an in vitro and in silico approach. World J. Microbiol. Biotechnol. 2022;38(3):44.", "ArticleIdList": ["35064842"]}, {"Citation": "Tao Z., et al. Flavone inhibits Staphylococcus aureus virulence via inhibiting the sae two component system. Microb. Pathog. 2023;180", "ArticleIdList": ["37148922"]}, {"Citation": "Lee J.H., et al. Flavone reduces the production of virulence factors, staphyloxanthin and \u03b1-hemolysin, in Staphylococcus aureus. Curr. Microbiol. 2012;65(6):726\u2013732.", "ArticleIdList": ["22965624"]}, {"Citation": "Alvarado-Sansininea J.J., et al. Quercetagetin and patuletin: antiproliferative, necrotic and apoptotic activity in tumor cell lines. Molecules. 2018;23(10)", "ArticleIdList": ["PMC6222523", "30304821"]}, {"Citation": "Eissa I.H., et al. A new anticancer semisynthetic theobromine derivative targeting EGFR protein: CADDD study. Life. 2023;13(1):191.", "ArticleIdList": ["PMC9867533", "36676140"]}, {"Citation": "Faizi S., et al. Antibacterial and antifungal activities of different parts of Tagetes patula.: Preparation of patuletin derivatives. 2008;46(5):309\u2013320."}, {"Citation": "Tereschuk M.a.L., et al. Antimicrobial activity of flavonoids from leaves of Tagetes minuta. J. Ethnopharmacol. 1997;56(3):227\u2013232.", "ArticleIdList": ["9201613"]}, {"Citation": "Metwaly A.M., et al. The computational preventive potential of the rare Flavonoid, Patuletin, isolated from Tagetes patula, against SARS-CoV-2. Plants. 2022;11(14):1886.", "ArticleIdList": ["PMC9323967", "35890520"]}, {"Citation": "Weinstein M.P., Lewis J.S. 2nd, the clinical and laboratory standards Institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. J. Clin. Microbiol. 2020;58(3)", "ArticleIdList": ["PMC7041576", "31915289"]}, {"Citation": "Stepanovi\u0107 S., et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. Apmis. 2007;115(8):891\u2013899.", "ArticleIdList": ["17696944"]}, {"Citation": "Kossakowska-Zwierucho M., et al. Factors determining Staphylococcus aureus susceptibility to photoantimicrobial chemotherapy: RsbU activity, staphyloxanthin level, and membrane fluidity. Front. Microbiol. 2016;7:1141.", "ArticleIdList": ["PMC4949386", "27486456"]}, {"Citation": "Elkaeed E.B., et al. Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase in silico approach. Antivir. Ther. 2023;28(5)", "ArticleIdList": ["37669909"]}, {"Citation": "Suleimen Y.M., et al. Isolation and in silico inhibitory potential against SARS-CoV-2 RNA polymerase of the rare kaempferol 3-O-(6 \u2033-O-acetyl)-Glucoside from calligonum tetrapterum. Plants. 2022;11(15):2072.", "ArticleIdList": ["PMC9370365", "35956550"]}, {"Citation": "Liu C.I., et al. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science. 2008;319(5868):1391\u20131394.", "ArticleIdList": ["PMC2747771", "18276850"]}, {"Citation": "Brooks B.R., et al. CHARMM: the biomolecular simulation program. J. Comput. Chem. 2009;30(10):1545\u20131614.", "ArticleIdList": ["PMC2810661", "19444816"]}, {"Citation": "Jo S., et al. CHARMM-GUI PDB manipulator for advanced modeling and simulations of proteins containing nonstandard residues. Adv. Protein Chem. Struct. Biol. 2014;96:235\u2013265.", "ArticleIdList": ["PMC4739825", "25443960"]}, {"Citation": "Tuccinardi T. What is the current value of MM/PBSA and MM/GBSA methods in drug discovery? Expet Opin. Drug Discov. 2021;16(11):1233\u20131237.", "ArticleIdList": ["34165011"]}, {"Citation": "Bouysset C., Fiorucci S. ProLIF: a library to encode molecular interactions as fingerprints. J. Cheminf. 2021;13:1\u20139.", "ArticleIdList": ["PMC8466659", "34563256"]}, {"Citation": "Salentin S., et al. PLIP: fully automated protein\u2013ligand interaction profiler. Nucleic Acids Res. 2015;43(W1):W443\u2013W447.", "ArticleIdList": ["PMC4489249", "25873628"]}, {"Citation": "Tubiana T., et al. TTClust: a versatile molecular simulation trajectory clustering program with graphical summaries. J. Chem. Inf. Model. 2018;58(11):2178\u20132182.", "ArticleIdList": ["30351057"]}, {"Citation": "Amadei A., et al. Essential dynamics of proteins. Proteins. 1993;17(4):412\u2013425.", "ArticleIdList": ["8108382"]}, {"Citation": "Papaleo E., et al. Free-energy landscape, principal component analysis, and structural clustering to identify representative conformations from molecular dynamics simulations: the myoglobin case. J. Mol. Graph. Model. 2009;27(8):889\u2013899.", "ArticleIdList": ["19264523"]}, {"Citation": "De Vivo M., et al. Role of molecular dynamics and related methods in drug discovery. J. Med. Chem. 2016;59(9):4035\u20134061.", "ArticleIdList": ["26807648"]}, {"Citation": "Zhao Z., Bourne P.E. Harnessing systematic protein-ligand interaction fingerprints for drug discovery. Drug Discov. Today. 2022;27(10)", "ArticleIdList": ["35850431"]}, {"Citation": "Salentin S., et al. From malaria to cancer: computational drug repositioning of amodiaquine using PLIP interaction patterns. Sci. Rep. 2017;7(1)", "ArticleIdList": ["PMC5595859", "28900272"]}, {"Citation": "Desdouits N., et al. Principal Component Analysis reveals correlation of cavities evolution and functional motions in proteins. J. Mol. Graph. Model. 2015;55:13\u201324.", "ArticleIdList": ["25424655"]}, {"Citation": "Pinto H.B., et al. The antivirulence compound myricetin possesses remarkable synergistic effect with antibacterials upon multidrug resistant Staphylococcus aureus. Microb. Pathog. 2020;149", "ArticleIdList": ["33075517"]}, {"Citation": "Iranshahi M., et al. Protective effects of flavonoids against microbes and toxins: the cases of hesperidin and hesperetin. Life Sci. 2015;137:125\u2013132.", "ArticleIdList": ["26188593"]}, {"Citation": "Wen Q.H., et al. Inhibition of biofilm formation of foodborne Staphylococcus aureus by the citrus flavonoid naringenin. Foods. 2021;10(11)", "ArticleIdList": ["PMC8622481", "34828898"]}, {"Citation": "Lopes L.A.A., et al. Inhibitory effects of flavonoids on biofilm formation by Staphylococcus aureus that overexpresses efflux protein genes. Microb. Pathog. 2017;107:193\u2013197.", "ArticleIdList": ["28365326"]}, {"Citation": "Hu Y., et al. Silico prediction of human organ toxicity via artificial intelligence methods. Chem. Res. Toxicol. 2023;36(7):1044\u20131054.", "ArticleIdList": ["37300507"]}]}], "History": [{"Year": "2023", "Month": "10", "Day": "8"}, {"Year": "2023", "Month": "12", "Day": "18"}, {"Year": "2024", "Month": "1", "Day": "3"}, {"Year": "2024", "Month": "1", "Day": "31", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "1", "Day": "31", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "31", "Hour": "4", "Minute": "25"}, {"Year": "2024", "Month": "1", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["38293404", "PMC10824781", "10.1016/j.heliyon.2024.e24075", "S2405-8440(24)00106-3"]}}]}